The Institute of Weight Control Research (IWCR) has been researching the benefits of weight loss surgery in the severely obese for over a decade. We have studied the effects of obesity, the health benefits of weight loss and the optimal care of the patient undertaking weight loss surgery. We have now treated more than 6000 patients during the last 15 years and have published many articles on the results of our studies into the outcomes of this surgery.
The Institute of Weight Control is also at the forefront of developing and evolving surgical techniques to perform gastric sleeve resections and bypass operations and researching their weight loss benefits.
Current Research Studies
- Revisional Surgery following gastric banding: two staged approach improves safety
- Repairing Hiatus Hernias with or without BioA mesh during gastric sleeve resection
- Reflux in patients undergoing gastric sleeve resection.
- Omega Loop bypass as a primary of revisional procedure
Previous Research Studies
- Studies in the efficacy of the adjustable gastric band
- Role of weight loss in the management of type 2 diabetes
- Studies on quality of life following weight loss with the adjustable gastric band
- Studies on pressure adjustment of bands
- Studies on the Attune self adjusting gastric band
- New Technologies: VBLC Therapy for weight reduction
- New Devices: The paragastric implant
- New Procedures: Gastric plication as an alternative to sleeve gastrectomy
- Dietary regiments before and after bariatric surgery
We have learned much from the studies conducted at the Institute of Weight control including the following:
Since the introduction of the gastric band back in 2002, over 3500 patients have had treatment for their obesity using this device here at the Institute of Weight Control. Studies have shown:
- Gastric banding is a safe procedure
- On average gastric banding leads to between 40 to 50% of excess weight loss
- Weight loss following gastric banding leads to remission and/or improvement in most of the problems caused by obesity
- Weight loss following gastric banding leads to improvement in quality of life
- Approximately 30% of patients fail to lose significant weight or regain weigh after a gastric band and require removal of the band and sleeve or bypass surgery
Weight loss using the adjustable gastric band leads to better control of diabetes, reduced medication and in some instances abolishes the need for medication. Ongoing studies are looking at the role of adjustable gastric bands versus the gastric sleeve and gastric plication and their effectiveness.
Currently all gastric bands are adjusted using saline. The optimal fill volume allows the patient to eat as little as possible as they are no longer hungry. In future it may be possible to adjust bands by recording the pressure within the band as opposed to the volume much like filling your car tyre at a certain pressure. Measuring "pressure" may be more physiological and meaningful.
The Attune tubing accessory is an attachment to the gastric band which is being currently tested at the Institute of Weight Control. The Attune tubing has pods or reservoirs which contain extra saline, which is thought may allow the band to be more distensible. Too little inflation of the band can result in the feeling of hunger and lack of weight loss, whilst too much inflation of the band can cause too much restriction, increasing the risk of heart burn and vomiting. Even when the band is optimally adjusted, patients may experience regurgitation or vomiting if they eat too quickly as some nutritious foods tend to be more fibrous and chewy. It is hoped that the Attune tubing may make band adjustments easier, less frequent and reduce regurgitation and/or vomiting.
The Institute of Weight Control has been working with Enteromedics in the development of a vagal blocking system (VBLOC) for the past 6 years. The innovative neuro-blocking therapy results in increased satiety, reduces hunger and hence is effective in weight reduction and in treating type 2 diabetes and hypertension. VBLOC Therapy delivers low energy electrical impulses via a pacemaker like device that blocks signals in the vagus nerve, thereby reducing appetite. Unfortunately, the FDA trial did not prove the efficacy of the device and it is not commercially available in Australia.
The para gastric implant is a kidney shaped inflatable balloon that is inserted using key hole surgery and sits on top of the stomach preventing it from expanding when we eat. The implant was designed to occupy the space that the stomach would normally occupy when we eat thereby limiting your capacity to eat. The implant does not involve any cutting, stapling or removal of any organs. Also, vomiting does not see to be a problem and patients an tolerate a better range of foods unlike gastric banding. The para gastric implant is under clinical investigation. Unfortunately, the clinical study was closed in 2013.
Although the sleeve gastrectomy results in weight loss of over 50% of excess weight, it is not without risk. There have been a number of reports of gastric leaks with a risk of about 1%. The gastric plication operation involves invaginating the stomach onto itself without the need to surgically remove it. It is under clinical trial investigation.
Food products have been developed which are nutritionally sound and achieve satiety with minimal calories. These are taken prior to surgery in order to address the problems with fatty livers and then after the surgery during the healing and transition to normal diet phases. The food comes under the name of Fulfil and is recommend for all IWC patients.
All the projects the Institute is involved in have the approval of an ethics committee e.g. the Bellberry Human Research Ethics Committee.
Our extensive database enables us to track a patient’s clinical assessment and progress. It also enables us to conduct research on how effective the procedure has been in terms of individual progress as well as being able to examine what the average weight loss is at any given point in time for all patients.It must be stated that when patients information is used for research that it is "de-identified", which means that no identifying markers will be used and patients will only be identified by their file number and initials.